Lyra Therapeutics Price Chart
Lyra Therapeutics Volume Chart
Lyra Therapeutics Market Segments
Regular Trading Hours
+0.05(+3.84%)
| Open | $1.30 |
|---|---|
| Close | $1.35 |
| Low | $1.30 |
| Low Change | -0.00 (-0.31%) |
| High | $1.42 |
| High Change | +0.12 (+9.23%) |
| Range | $0.12 |
| Volume | 9.437K |
| Dollar Volume | $12.74K |
Premarket
+0.00(+0.00%)
| Open | $1.40 |
|---|---|
| Close | $1.40 |
| Low | $1.40 |
| Low Change | 0.00 (0.00%) |
| High | $1.40 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 394 |
| Dollar Volume | $551.60 |
After Hours Yesterday
+0.00(+0.00%)
| Open | $1.31 |
|---|---|
| Close | $1.31 |
| Low | $1.31 |
| Low Change | 0.00 (0.00%) |
| High | $1.31 |
| High Change | +0.00 (+0.01%) |
| Range | $0.00 |
| Volume | 880 |
| Dollar Volume | $1.15K |
Regular Trading Hours Yesterday
+0.02(+1.56%)
| Open | $1.28 |
|---|---|
| Close | $1.30 |
| Low | $1.24 |
| Low Change | -0.04 (-3.13%) |
| High | $1.32 |
| High Change | +0.04 (+3.13%) |
| Range | $0.08 |
| Volume | 11.362K |
| Dollar Volume | $14.77K |
Premarket Yesterday
*No Trades in Segment
Lyra Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.30 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.25 |
| 20 Day Moving Average (SMA20) | $1.34 |
| 50 Day Moving Average (SMA50) | $2.00 |
| 100 Day Moving Average (SMA100) | $3.30 |
| 200 Day Moving Average (SMA200) | $6.00 |
Lyra Therapeutics Statistics
| Average Volume (30 Days) | 68.41K |
|---|---|
| P/E Ratio (Current) | -.07 |
| EPS (Current) | -$18.56 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$34.18M |
| Cash Ratio | 2.33 |
| Current Ratio | 2.43 |
| Quick Ratio | 2.43 |
| Debt to Equity | 0.00 |
| Enterprise Value | -$19.75M |
| EV to EBITDA | 0.62 |
| EV to Sales | -32.91 |
| Price to Book | -0.53 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 3.85 |
| Return on Assets | -0.75% |
| Return on Equity | 7.61% |
Lyra Therapeutics Stock Splits
There has been 1 stock split for Lyra Therapeutics (LYRA). The reverse stock split occured on May 28, 2025 and reduced the outstanding shares at a ratio of 50:1.
| Date | Type | Ratio |
|---|---|---|
| May 28, 2025 | Reverse | 50:1 |
Lyra Therapeutics Dividends
There have been no dividends for Lyra Therapeutics (LYRA).